Channel Expansion Dp Derm is the exclusive U.S. distributor of Dermapen 4 and Dp Dermaceuticals, presenting a clear opportunity to upsell to clinics and salons already investing in microneedling gear with bundled homecare protocols and the Exo-Grow collection to boost client results and retention.

Exosome Advantage With the recent Exo-Grow Collection launch and HLA-G exosome breakthrough, target aesthetic clinics and medspas emphasizing anti-aging treatments as a premium offering, paired with in-clinic serums and take-home boosters to drive higher average order value.

Performance Credibility Leverage FDA-cleared Dermapen 4 leadership and proven outcomes to position as a trusted provider for safe, effective skin regeneration solutions, encouraging clinics to standardize Dermapen 4 protocols across services.

Tech & Enablement Utilize the existing tech stack (Salesforce, Monday.com, QuickBooks Online, analytics tools) to automate lead nurturing, track pipeline health, and tailor outreach to clinics and suppliers within the personal care channel that already use similar ecosystems.

Growth Profile Financial health signals and a mid-market scale profile (revenue in the tens of millions, 11–50 employees) align with mid-sized distributors and multi-location salons; target growth-minded accounts looking for scalable microneedling and skincare program implementations.